Quick Takeaways
- Thomas A. Satterfield Jr. filed SCHEDULE 13G/A for Edesa Biotech, Inc. Common Stock, without par value (EDSA).
- Disclosed ownership: 6.7%.
- Date of event: 31 Dec 2024.
Thomas A. Satterfield Jr. - 31 Dec 2024 SCHEDULE 13G/A Report for Edesa Biotech, Inc. Common Stock, without par value (EDSA)
- Filing Manager
- Thomas A. Satterfield Jr.
- Reporting Manager
- Thomas A. Satterfield, Jr.
- Symbol
- EDSA
- Shares outstanding
- 3,465,090 shares
- Disclosed Ownership
- 232,161 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 08:00:37 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 18 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Thomas A. Satterfield Jr. disclosed 6.7% ownership in Edesa Biotech, Inc. Common Stock, without par value (EDSA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 08:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 6.7% | 232,161 | 40,247 | 191,914 | /s/ Thomas A. Satterfield, Jr. | Thomas A. Satterfield, Jr. |